Thursday, August 26, 2010 |
3:00-4:30 p.m. Eastern
2:00-3:30 p.m. Central |
1:00-2:30 p.m. Mountain
12:00-1:30 p.m. Pacific |
Organizations need to learn more about controlling large costs like those for specialty drugs. Experts estimate that between 10% and 25% of all drug costs are currently for specialty drugs and specialty drug costs are expected to grow exponentially in the coming years. Attend this webcast and discover what you need to know to effectively decrease and control specialty drug costs. Topics to be covered include:
- How to define contractually what constitutes a specialty drug
- Learn how to generate a drug-by-drug specialist list and obtain a ‘minimum discount guarantee’ for every drug listed
- Discover how to work with your PBM to pass through rebates and possible other financial benefits
- How to control the costs of ‘new-to-market' specialty drugs through a default discount guarantee
Presenter
Registration Fee
Unable to attend at this day and time?
The recorded version of this presentation will be available for purchase on CD (within two weeks) with the audio presentation and handouts accessible via your computer.
Purchase the CD (ISCEBS members order here, using item #TW199 and price $176)
$195 International Foundation or ISCEBS member ($176 + S&H)
$255 nonmember ($236 + S&H)